Gene silencing — LLMpedia

Contents

Gene silencing is a regulation mechanism that prevents the expression of a specific gene or genes by RNA interference (RNAi) or other methods, often used in molecular biology research, particularly in Drosophila melanogaster and Caenorhabditis elegans studies. This technique has been employed by scientists such as Andrew Fire and Craig C. Mello to understand the function of genes in organisms like Homo sapiens and Mus musculus. Gene silencing has also been used in cancer research at institutions like the National Cancer Institute and Memorial Sloan Kettering Cancer Center. The discovery of gene silencing has been recognized with awards such as the Nobel Prize in Physiology or Medicine, which was awarded to Andrew Fire and Craig C. Mello in 2006 for their work on RNA interference at Carnegie Institution for Science and University of Massachusetts Medical School.

Introduction to Gene Silencing

Gene silencing is a crucial mechanism that helps regulate gene expression in cells, including those of Homo sapiens, Mus musculus, and Drosophila melanogaster. This process involves the suppression of specific genes or genetic pathways, often through the use of small interfering RNA (siRNA) or microRNA (miRNA), which are key components of the RNA interference (RNAi) pathway, as studied by researchers at Harvard University and Stanford University. The discovery of gene silencing has been instrumental in understanding the function of genes in organisms, including Caenorhabditis elegans and Arabidopsis thaliana, and has been recognized by awards such as the Lasker Award and Breakthrough Prize in Life Sciences. Gene silencing has also been used in research at institutions like the National Institutes of Health (NIH) and European Molecular Biology Laboratory (EMBL).

The mechanisms of gene silencing involve the use of small interfering RNA (siRNA) or microRNA (miRNA) to target specific messenger RNA (mRNA) molecules, as described by scientists like David Baulcombe and Phillip Sharp at University of Cambridge and Massachusetts Institute of Technology (MIT). This process is mediated by the RNA-induced silencing complex (RISC), which is composed of proteins such as Argonaute and Dicer, as studied by researchers at University of California, Berkeley and University of Oxford. Gene silencing can also occur through other mechanisms, including DNA methylation and histone modification, which are regulated by enzymes such as DNA methyltransferase and histone deacetylase, as investigated by scientists at Johns Hopkins University and University of California, Los Angeles (UCLA). The study of gene silencing has been facilitated by the use of model organisms like Drosophila melanogaster and Caenorhabditis elegans, which are commonly used in research at institutions like the Whitehead Institute and Baylor College of Medicine.

There are several types of gene silencing, including post-transcriptional gene silencing (PTGS) and transcriptional gene silencing (TGS), as described by researchers like Victor Ambros and Gary Ruvkun at University of Massachusetts Medical School and Harvard University. PTGS involves the degradation of specific messenger RNA (mRNA) molecules, while TGS involves the suppression of gene transcription, as studied by scientists at Stanford University and University of California, San Francisco (UCSF). Gene silencing can also be classified into different types based on the mechanism of action, including RNA interference (RNAi) and microRNA (miRNA)-mediated silencing, which are regulated by proteins such as Dicer and Argonaute, as investigated by researchers at University of Oxford and University of Cambridge. The study of gene silencing has been recognized by awards such as the Wolf Prize in Medicine and Albert Lasker Award for Basic Medical Research, which have been awarded to scientists like Andrew Fire and Craig C. Mello for their work on RNA interference at Carnegie Institution for Science and University of Massachusetts Medical School.

Gene silencing has several applications in biotechnology and medicine, including the development of gene therapy and cancer treatment, as investigated by researchers at National Cancer Institute and Memorial Sloan Kettering Cancer Center. Gene silencing can be used to suppress the expression of disease-causing genes, such as those involved in cancer and genetic disorders, as studied by scientists at University of California, Los Angeles (UCLA) and University of Pennsylvania. Gene silencing can also be used to develop vaccines and therapeutic agents, such as siRNA-based therapies, which are being developed by companies like Alnylam Pharmaceuticals and Ionis Pharmaceuticals. The use of gene silencing in agriculture has also been explored, with applications in crop improvement and pest control, as investigated by researchers at University of California, Davis and Cornell University.

The regulation and ethics of gene silencing are complex issues, involving considerations of genetic privacy and informed consent, as discussed by experts at National Academy of Sciences and World Health Organization (WHO). The use of gene silencing in human subjects is regulated by laws and guidelines, such as the Human Genome Project and Genetic Information Nondiscrimination Act (GINA), which are enforced by agencies like the Food and Drug Administration (FDA) and National Institutes of Health (NIH). The ethics of gene silencing have been debated by scholars like Francis Collins and Eric Lander at National Human Genome Research Institute and Broad Institute. The development of gene silencing technologies has also raised concerns about patent law and intellectual property rights, as investigated by researchers at Harvard University and Stanford University.

Several techniques are available for gene silencing, including RNA interference (RNAi) and microRNA (miRNA)-mediated silencing, as described by researchers like David Baulcombe and Phillip Sharp at University of Cambridge and Massachusetts Institute of Technology (MIT). Other techniques include DNA methylation and histone modification, which are regulated by enzymes such as DNA methyltransferase and histone deacetylase, as studied by scientists at Johns Hopkins University and University of California, Los Angeles (UCLA). The use of CRISPR-Cas9 gene editing technology has also been explored for gene silencing, as investigated by researchers at Broad Institute and University of California, Berkeley. The development of new techniques for gene silencing is an active area of research, with applications in biotechnology and medicine, as recognized by awards such as the Breakthrough Prize in Life Sciences and Lasker Award. Category:Genetics